Memorial Sloan Kettering Cancer Center
As the world’s largest comprehensive cancer center, Memorial Sloan Kettering Cancer Center (MSK) has devoted more than 130 years to exceptional patient care, cutting-edge research, and superb educational programs, making significant contributions to better understand, diagnose, and treat cancer. The close collaboration between laboratory science and clinical treatment is one of its unique strengths, enabling the institution to provide patients with the best care available today as the institution works to discover more effective strategies to prevent, control, and ultimately cure cancer. MSK’s education programs train future physicians and scientists whose knowledge and experience impact cancer treatment and biomedical research around the world.
MSK is one of 47 institutions in the United States that has been designated a Comprehensive Cancer Center by the National Cancer Institute, affirming its leadership in research, patient care, and education. MSK is an American Nurses Credentialing Center (ANCC) Magnet® designated institution, based on nursing excellence. MSK has over 17,300 total staff members, including more than 1,140 hospital attending physicians and 130 Sloan Kettering Institute (SKI) members, 3,720 registered nurses, and 12,300 support staff. In 2017, more than 23,500 patients were admitted to the 473-bed Memorial Hospital (MH), and more than 722,000 outpatient visits were accommodated at the Manhattan and regional facilities.
According to US News & World Report, MSK has ranked as one of the top two hospitals for cancer care in the country for more than 25 years and among the nation’s top pediatric hospitals for cancer care. The 2018 Best Doctors issue of New York magazine recognizes more cancer physicians from Memorial Sloan Kettering than from any other hospital in the New York metropolitan area.
Patient care is a team effort at MSK, where more than a dozen multidisciplinary cancer care teams combine the expertise and experience of numerous specialists to ensure the best possible treatment. MSK’s physicians have an extraordinary depth and breadth of experience in diagnosing and treating all forms of the disease, from the most common to the rarest. Each year, they treat more than 400 different subtypes of cancer. This level of specialization can often have a dramatic effect on a patient’s chances for a cure or for control over his or her cancer. MSK offers a full range of programs to help patients and families throughout all phases of treatment, including support groups, genetic counseling, assistance with pain and symptom management, rehabilitation, integrative medicine services, and assistance navigating life after treatment.
One of MSK’s greatest strengths is the interconnectedness between scientists and physicians, which enables rapid application of laboratory research in the clinical setting. In 2017, MSK’s physicians led more than 1,000 clinical research trials for pediatric and adult cancers. With more than 120 research laboratories, MSK is home to more than 38 state-of-the-art core facilities that provide the research community with the latest research technology and a wide range of expert services. Between 1980 and 2015, the US Food and Drug Administration approved nine drugs developed in MSK labs for marketing – a success rate unmatched by any other cancer center.
Research at the SKI is dedicated to understanding the biology of cancer through eight major research programs. Laboratories are also led by MH investigators in a variety of its departments. Investigators collaborate closely with Memorial Hospital clinical investigators to speed findings from the lab to the patient. MSK’s extensive research program includes areas that focus on basic laboratory research, translational research that bridges discoveries made in the lab and those made in the clinic, as well as mathematical and computational research directed at interpreting biomedical data.
Education and Training
MSK’s training programs prepare physicians and scientists for leadership roles in the biomedical sciences. Its collaborations with The Rockefeller University, Cornell University, and Weill Cornell Medical College offer PhD programs in chemical biology, computational biology and medicine, and the medical sciences. The Center also partners with Weill Cornell Medical College and The Rockefeller University to offer a MD/PhD degree for aspiring physician-scientists. In 2004, The Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at MSK was established to expand MSK’s educational mission.
MSK offers postgraduate clinical fellowship programs to train physicians who seek special expertise in a particular type of cancer, as well as postgraduate research fellowships that provide physicians and scientists with advanced laboratory research training. With faculty appointments at the Weill Cornell Medical College, MSK’s clinical staff members train residents and medical students as well.
Growth and Expansion
MSK has undergone a major expansion in the last decade, with new construction and renovations designed to meet the growing needs of both patient care and the hospital’s scientific initiatives. MSK continues to expand its clinical and research enterprises, building new facilities, including the new, stateof- the art Laboratory Medicine building, to extend MSK’s reach into communities while simultaneously advancing pioneering research programs. Both patient care revenue and net operating revenue have increased year over year between 2013 and 2017. In the past five years, MSK has increased its total number of staff by more than 5,100 employees.
In 2016, MSK opened the Josie Robertson Surgery Center, with 12 operating rooms and 16 stories. This center is the first of its kind; a freestanding outpatient and short-stay cancer surgery facility that meets the highest standards for sustainability and delivers exceptional care to patients. A $2.5 billion capital expansion, including the 750,000 square foot David H. Koch Center for Cancer Care, will be complete in 2019.
MSK is continuously expanding its regional network of cancer treatment services, with 25 sites located in New Jersey, Long Island, and Westchester County. Construction of a new MSK Nassau facility in Uniondale, New York has been completed, and opened for patient care in the spring of 2019. The previously mentioned David H. Koch Center for Cancer Care will open in late 2019, adding another care location. MSK’s total outpatient visits have increased from over 571,922 visits in 2013 to 722,238 visits in 2017.
For more information please refer to: www.mskcc.org
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center
The Department of Laboratory Medicine at Memorial Sloan Kettering Cancer Center, chaired by Dr. Melissa Pessin, was transformed in 2011 into its current structure. The Department of Laboratory Medicine provides diagnostic testing for all patients seen at MSK and its Manhattan and regional sites.
The department includes the following services:
- Clinical Chemistry (including Point-of Care);
- Clinical Hematology (including Coagulation);
- Cellular Immunology;
- Clinical Microbiology;
- Hematopathology (jointly with the Pathology Department); and,
- Cell Therapy and Transfusion Medicine (including blood bank, donor room, and apheresis).
The department has recently relocated to a new, state-of-the art Laboratory Medicine building with individual space for each service and dedicated resources for innovation activities. Located on East 64th Street between First and Second Avenues, the new center for Laboratory Medicine maximizes operational efficiency and allows for the development of new tests, permitting the Laboratory Medicine team to provide test results faster, more accurately, and generating more useful information for the treatment teams.
The main campus operation is comprised of seven laboratories and the highest-volume hospital-based blood donor room in the city of New York. In addition, there are six regional sites located in New Jersey, Westchester, Long Island and several outpatient sites in Manhattan that perform focused, on-site testing as needed to support local patient treatment. Over the course of a typical weekday, the department processes 2000 samples and performs 8,000 clinical laboratory tests. Each month, MSK transfuses over 3,500 blood products and performs 620 collections of donor blood and other products.
The Department of Laboratory Medicine strives to create and maintain a diverse environment among faculty and staff that mirrors its diverse patient population. MSK, and the department, are committed to promoting and supporting diversity and inclusion in its research, clinical and educational missions to meet the needs of its faculty, staff, students, and the communities it serves. MSK and the department welcome differences in race, ethnicity, sexual orientation, religion, gender and age among its faculty and staff as well as within its patients and their families. MSK and the department are fostering a culturally competent, inclusive, and respectful environment for all, as MSK believes diversity within its department encourages broader perspectives and combats negative stereotyping. This optimizes MSK’s ability to provide the best possible healthcare to all.
For more information please refer to: www.mskcc.org/departments/laboratory-medicine
The Role: Chief, Transfusion Medicine and Cell Therapy Laboratory Service
The Department of Laboratory Medicine at Memorial Sloan Kettering Cancer Center welcomes nominations and invites applications for the position of Service Chief of the Transfusion Medicine and Cell Therapy Laboratory Service. The Department is seeking an exceptional academic physician to lead and expand these vital clinical and laboratory services.
The services offered by the Transfusion Medicine and Cell Therapy Laboratories are both high in complexity and volume. In addition to transfusing approximately 47,000 products annually, Transfusion Medicine has an active consultative service as well as oversight of the blood management and quality programs. The Donor Room collects 4,900 allogeneic blood products in addition to 700 stem cell collections and therapeutic procedures. The Cell Therapy Laboratory supports 650 transplants annually which require cutting edge cell processing techniques.
The Chief of the Transfusion Medicine and Cell Therapy Laboratory Service will report directly to the Chair of the Department of Laboratory Medicine, Dr. Melissa Pessin, and will play a critical leadership role within the department. The Chief will be responsible for overseeing the clinical, academic, and administrative aspects of the Service. MSK seeks a balanced and experienced physician leader, with the ability to advance the clinical, research, and education missions of the service. The Service Chief should be an outstanding clinician with operations experience a proven ability to lead cutting edge research, a deep appreciation for the academic mission of MSK. MSK seeks a proven leader with experience in a complex academic setting.
The position will carry a rank of Associate or Attending Physician, depending upon experience. In addition to participating in the diagnostic work and expansion of the Transfusion Medicine and Cell Therapy Service, the Service Chief will lead and promote clinical-pathologic and laboratory correlative research in transfusion medicine and cell therapy and provide mentorship and career development for junior faculty.
- Chair, Department of Laboratory Medicine
Other Key Relationships:
- Medical Director of Transfusion Medicine
- Medical Director of Cell Therapy
- 7 faculty members
- Service Chief of Clinical Chemistry
- Service Chief of Clinical Hematology
- Service Chief of Cellular Immunology
- Service Chief of Clinical Microbiology
- Service Chief of Hematopathology
Memorial Sloan Kettering Cancer Center is seeking a senior-physician leader, for the Chief of the Transfusion Medicine and Cell Therapy Laboratory Service in the Department of Laboratory Medicine. The ideal candidate will possess the following qualifications, experience, and personal traits:
- An accomplished, Board Certified physician executive with an outstanding and deep passion for, commitment to, and track record of accomplishment in clinical care, research, and education.
- A terminal medical degree with the ability to obtain a NYS Medical License
- Board Certification from the American Board of Pathology in Clinical Pathology or Anatomic Pathology/Clinical Pathology
- Subspecialty board certification from the American Board of Pathology in Transfusion Medicine/Blood banking
- Eligibility to obtain NYS DOH COQs in the appropriate categories related to transfusion medicine/blood banking practice is also mandatory
- A minimum of 5 years of administrative and leadership experience at an academic institution or cancer center as Service Chief, Medical Director, Clinical Program Director, Research Director or related leadership role.
- Experience in research, training, and clinical achievement, commensurate with appointment to the faculty at the rank of Associate or Full Member
- A dedicated clinician with an outstanding reputation for clinical excellence; past clinical experience in both Transfusion Medicine or Cellular Therapy is ideal.
- Experience overseeing clinical operations and quality programs.
- Evidence of innovation and clinical research experience and productivity to elevate the academic profile of the Service.
- Experience building new and innovative clinical and multi-disciplinary programs, in alignment with organizational priorities and patient needs.
- Excellent communication and listening skills and a demonstrated ability to unite and inspire a diverse group of faculty and staff members.
- Experience developing and mentoring junior faculty and clinical leaders; demonstrated ability to identify and recruit high-performing, diverse faculty at all levels.
- Ability to respond effectively to elements that drive competitive advantage under dynamic conditions, such as healthcare industry changes, competitor actions, legal/regulatory changes and technological trends.
- An outstanding leader who inspires, builds, and motivates teams.
- A person of the highest personal and professional ethics and integrity.
- Capable of establishing and nurturing trusted relationships, internally and externally.
- Collaborative relationship-building skills, with an ability to successfully partner and build consensus with key internal and external stakeholders at all levels of the organization.
- An outstanding communicator and collaborator with the leadership presence that commands respect and influence across MSK’s diverse constituencies.
- A fair and objective leader with strong listening skills.
- An entrepreneurial spirit, who is not afraid to take risks.
- Capable of striking a balance between providing consistent care for patients today, but also looking to the future to ensure MSK remains on the cutting edge.
- A visible and inspiring advocate of MSK and the Department of Laboratory Medicine.
Application / Nomination Procedure
The Search Committee invites inquiries, nominations, and applications for the position of Chief of the Transfusion Medicine and Cell Therapy Laboratory Service in the Department of Laboratory Medicine. Dr. Ellinor Peerschke, the Chair of the Search Committee, the Search Committee, and Sonia Romá, Manager of Academic Recruitment, are partnering in this search with Charles Kaler and Sarah Schumacher of Russell Reynolds Associates.
Prospects nominated and/or those who wish to be considered by the Search Committee should provide an electronic version of their
curriculum vitae and letter of interest briefly detailing personal area(s) of scientific and clinical interest and summarizing past and current administrative roles, including scope of responsibility and accomplishments in each.
The confidential review of nominations and expressions of interest will begin immediately until an appointment is made. To be ensured of full consideration, email a curriculum vitae and supporting materials to MSKCC.TM@russellreynolds.com.
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.